Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Maternal and Neonatal Group B Streptococcus in Brazil: A Systematic Review Highlighting Epidemiological Gaps and Opportunities for Improved Prevention.

Created on 20 Nov 2026

Authors

Tatiana Castro Abreu Pinto, Laura Maria Andrade Oliveira, Natalia Silva Costa, André Rio-Tinto, Ana Clarisse Merces, Leandro Correa Simoes, Ana Caroline Nunes Botelho, Prescilla Emy Nagao, Pamella Silva Lannes-Costa, Gabriela da Silva Santos, Bruna Alves Pimentel Hecht, Anjo Gabriel Carvalho, Najla Benevides Matos, Cilicia Nascimento, Carla Romano Taddei, Kirsty Le Doare, Nuria Sanchez Clemente

Published in

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. Pages 109265. Nov 19, 2026. Epub Nov 19, 2026.

Abstract

Group B Streptococcus (GBS) is a major cause of maternal and neonatal morbidity and mortality worldwide. In Brazil, national data on GBS epidemiology remain scarce. We aimed to provide a comprehensive synthesis of maternal carriage, neonatal disease, serotype distribution, and antimicrobial resistance. We did a systematic review and meta-analysis (PROSPERO CRD42023427476) following PRISMA 2020. PubMed/MEDLINE, EMBASE, Web of Science, Scopus, Cochrane Library, LILACS/SCIELO, and CINAHL were searched for studies published between January 1, 2000, and December 31, 2024. Meta-analyses were performed using StataNow/SE version 19.5 (StataCorp, College Station, TX, USA). Pooled prevalence estimates with 95% confidence intervals were calculated using the metaprop command and random-effects models, and between-study heterogeneity was assessed using the I² statistic. Forest plots were generated to illustrate pooled estimates. Forty-nine studies were included. Forty-three studies (n=64,658 samples) reported maternal GBS carriage, with a pooled prevalence of 17% (95% CI 14-20%; I2=98.55%). Eight studies, encompassing more than 32 million live births, assessed early-onset neonatal disease, and reported incidence estimates of 0.01-0.45 per 1,000 live births. Among 1,502 maternal and neonatal isolates, serotypes Ia, V, II and III predominated, in descending order of prevalence. Among 9,880 maternal isolates, pooled resistance to clindamycin and erythromycin was 12% and 14%, respectively; penicillin non-susceptibility was rare. GBS burden in Brazil is substantial but poorly defined. Strengthening laboratory diagnosis of invasive neonatal GBS disease, implementing accessible capsular serotyping methods, and expanding geographically representative surveillance are priorities to improve disease burden estimates and inform prevention policies, including future maternal GBS vaccine implementation.

PMID:
43057612
Bibliographic data and abstract were imported from PubMed on 20 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement